证券代码：603259 证券简称：药明康德 公告编号：临 2025-059 无锡药明康德新药开发股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 二、变更公司注册资本 的全部 A 股股份 15,775,377 股。 前述发行的 H 股已在香港联合交易所有限公司上市。 股份合计 17,350,340 股。 的全部 A 股股份 11,860,809 股。 根 据 上 述 股 份 变 动 情 况 ， 公 司 注 册 资 本 由 2,887,992,582 元 变 更 为 三、修改公司章程 根据上述取消监事会、公司注册资本及总股本变更事宜，并结合相关法律、 法规及规范性文件的最新修订情况，公司拟对《无锡药明康德新药开发股份有限 公司章程》（以下简称"《公司章程》"）的有关条款进行修订，修订内容如下： 无锡药明康德新药开发股份有限公司（以下简称"公司"）于 2025 年 9 月 注册资本、修改公司章程并办理工商变更登记的议案》。具体情况如下： 一、取消监事会 为进一步完善公司治理结构，落实中国证券监督管理委员会（以下简称"中 ...

Group 1 - The company is holding a shareholders' meeting to ensure the legal rights of all shareholders and maintain order and efficiency during the meeting [1][2] - Only authorized representatives, directors, supervisors, and invited personnel are allowed to attend the meeting, while others may be refused entry [1][3] - Shareholders have the right to speak, consult, and vote, but must register in advance and limit their speaking time to three minutes [2][3] Group 2 - The company proposes to cancel the supervisory board, transfer its powers to the audit committee of the board, and amend the company’s articles of association accordingly [5][6] - The registered capital of the company will change from 2,887,992,582 yuan to a new amount, reflecting changes in share structure [6] - The company plans to revise part of its corporate governance system to comply with updated regulations from the China Securities Regulatory Commission [6][8] Group 3 - The company seeks authorization for its investment department to dispose of its listed shares, with a total transaction amount not exceeding 15% of the latest audited net assets attributable to shareholders [9][8] - The authorization is valid for 12 months from the date of approval by the board or until the next annual meeting [9] - The company has already disposed of some shares under this authorization, and the impact on performance will be assessed cautiously [9]

证券代码：603259 证券简称：药明康德 公告编号：2025-062 ? 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 一、 召开会议的基本情况 (一) 股东大会类型和届次 无锡药明康德新药开发股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ? 股东大会召开日期：2025年9月23日 (三) 投票方式：本次股东大会所采用的表决方式是现场投票和网络投票 (二) 股东大会召集人：董事会 召开地点：上海淳大万丽酒店，上海市浦东新区迎春路 719 号 (五) 网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025 年 9 月 23 日 至2025 年 9 月 23 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东大会召开当日的交易时间段，即 9:15-9:25，9:30-11:30，13:00-15:00；通过互 联网投票平台的投票时间为股东大会召开当日的 9:15-15:00。 相结合的方式 ...

此通函為重要文件請即處理 閣下對本通函任何方面或應採取的行動如有任何疑問，應諮詢閣下的股票經紀或其他註冊證券 交易商、銀行經理、律師、專業會計師或其他專業顧問。 閣下如已售出或轉讓名下所有無錫藥明康德新藥開發股份有限公司的股份，應立即將本通函連 同隨附的代表委任表格送交買主或承讓人，或經手買賣或轉讓的銀行、股票經紀或其他代理商， 以便轉交買主或承讓人。 香港交易及結算所有限公司及香港聯合交易所有限公司對本通函的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示概不對因本通函全部或任何部分內容而產生或因倚賴 該等內容而引致的任何損失承擔任何責任。 WUXI APPTEC CO., LTD. * 無錫藥明康德新藥開發股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：2359） (1) 建議取消監事會、建議變更註冊資本及建議修訂公司章程； (2) 建議修訂本公司若干企業管治制度； (3) 建議授權本公司投資部處置本公司所持已上市流通股份； 及 (4) 臨時股東大會通告 謹定於2025年9月23日（星期二）下午二時三十分假座中國上海市浦東新區迎春路719號上海淳大 萬麗酒店舉行臨時股東 ...

Core Viewpoint - The document outlines the insider information management system of Wuxi AppTec Co., Ltd., aiming to regulate insider information handling, ensure confidentiality, and prevent insider trading, thereby protecting investors' rights and maintaining fair information disclosure practices. Group 1: Insider Information Management - The company establishes this system to comply with various laws and regulations, including the Company Law and Securities Law of the People's Republic of China, as well as guidelines from the Shanghai Stock Exchange and Hong Kong Securities and Futures Commission [1]. - Insider information is defined as non-public information that could significantly impact the company's operations, finances, or stock market prices [2][4]. - The company must maintain a record of individuals who have access to insider information, ensuring that their identities and the details of their knowledge are documented [5][6]. Group 2: Responsibilities and Obligations - Insider information must be kept confidential by designated individuals, including company directors, senior management, and significant shareholders [2][3]. - The company is responsible for ensuring that insider information is disclosed only to a limited number of individuals and that all necessary confidentiality agreements are in place [13]. - Any violations of the insider information management system can lead to disciplinary actions, including warnings, demotions, or even criminal prosecution if significant losses occur [9][16]. Group 3: Documentation and Reporting - The company is required to maintain and regularly update insider information records and significant event progress memos, which must be preserved for at least ten years [12]. - Following the public disclosure of insider information, the company must submit the relevant records to the Shanghai Stock Exchange within five trading days [12]. - The board of directors is responsible for ensuring the accuracy and completeness of the insider information records and must confirm this in writing [5].

无锡药明康德新药开发股份有限公司 银行间债券市场非金融企业 债务融资工具信息披露管理制度 （2025年修订） 无锡药明康德新药开发股份有限公司 银行间债券市场非金融企业 债务融资工具信息披露管理制度 第一章 总则 第一条 为规范无锡药明康德新药开发股份有限公司（以下简称"公 司"）在银行间债券市场发行非金融企业债务融资工具的信息披露行为，加强 信息披露事务管理，保护投资者合法权益，根据《中华人民共和国公司法》 《银行间债券市场非金融企业债务融资工具管理办法》《公司信用类债券信 息披露管理办法》以及中国银行间市场交易商协会（以下简称 "交易商协 会"）的《银行间债券市场非金融企业债务融资工具信息披露规则》等相关法 律、法规和规范性文件以及《无锡药明康德新药开发股份有限公司章程》 《无锡药明康德新药开发股份有限公司信息披露管理制度》等文件的规定， 特制定本制度。 第二条 本制度所称银行间债券市场非金融企业债务融资工具是指在 中国银行间债券市场发行的，约定在一定期限内还本付息的有价证券（以下 简称"债务融资工具"）。 本制度中所称信息，是指公司在债务融资工具发行时或存续期限内，对 发行债务融资工具的非金融企业偿债能 ...

Core Viewpoint - The document outlines the investor relations management measures of Wuxi AppTec Co., Ltd., aiming to enhance communication with investors, promote a stable relationship, and maximize shareholder and company value through compliance and transparency [1][2]. Group 1: Objectives of Investor Relations Management - The objectives include fostering a positive relationship with investors, establishing a stable investor base, creating a culture of respect for investors, and increasing transparency in information disclosure [2][3]. Group 2: Principles of Investor Relations Management - The basic principles include compliance with laws and regulations, equal treatment of all investors, proactive engagement with investors, and maintaining honesty and integrity in communications [3][4]. Group 3: Main Content and Communication Channels - The main content for investor relations includes company development strategies, legal disclosures, operational and financial information, ESG data, and shareholder rights [5][6]. - Multiple communication channels are utilized, such as the company website, new media platforms, and direct interactions like investor meetings and roadshows [6][7]. Group 4: Responsibilities and Implementation - The board secretary is responsible for investor relations management, supported by a dedicated department that handles daily operations and ensures the accuracy of information [10][11]. - The company is required to maintain a record of investor relations activities, including participant details and communication content, for at least three years [12]. Group 5: Training and Conduct Standards - Staff involved in investor relations must possess comprehensive knowledge of the company and industry, good communication skills, and a commitment to ethical conduct [11][29]. - The company must not disclose undisclosed significant information or engage in misleading practices during investor communications [29]. Group 6: Effectiveness of Information Disclosure - The company aims to enhance the effectiveness of information disclosure and ensure that reports are clear and accessible to investors [8][9]. - Investor meetings should be announced in advance and conducted in a manner that facilitates investor participation [9]. Group 7: Compliance and Amendments - The document will be effective upon approval by the board and will replace the previous investor relations management measures [13]. - Any conflicts with existing regulations will be resolved in favor of the applicable laws and guidelines [13].

Core Points - The document outlines the management system for the deferral and exemption of information disclosure by Wuxi AppTec Co., Ltd, ensuring compliance with relevant laws and regulations while protecting investors' rights [1][2] - The company and other obligated parties must carefully determine the deferral and exemption of information disclosure, following internal review procedures [2][3] Group 1: General Principles - The purpose of the system is to standardize the deferral and exemption of information disclosure, ensuring legal compliance and investor protection [1] - The system is based on various laws and regulations, including the Company Law and Securities Law of the People's Republic of China, as well as stock exchange rules [1] Group 2: Scope of Deferral and Exemption - Information that involves trade secrets or confidential business information can be deferred or exempted from disclosure if it meets specific criteria, such as potential harm to the company or others' interests [2][3] - If there is sufficient evidence that the information involves state secrets, it can also be exempted from disclosure [3] Group 3: Disclosure Review Procedures - The company must take effective measures to prevent the leakage of information that is deferred or exempted from disclosure [4][5] - The decision to defer or exempt disclosure must be documented, including the type of information and the internal review process [4][5] Group 4: Reporting Requirements - The company is required to submit relevant registration materials regarding deferred or exempted disclosures to the regulatory authority and stock exchange within ten days after the publication of periodic reports [5]

Core Viewpoint - The document outlines the information disclosure management system of Wuxi WuXi AppTec Co., Ltd., emphasizing the importance of timely, accurate, and complete information disclosure to protect investors' rights and comply with relevant laws and regulations. Group 1: General Principles - The company establishes this system to regulate information disclosure behavior and strengthen management of disclosure affairs [1] - Information disclosure obligations must be fulfilled timely and accurately, ensuring that all investors receive the same information simultaneously [2][3] - Directors and senior management must diligently ensure the authenticity and completeness of disclosed information [4] Group 2: Disclosure Obligations - The company must disclose significant operational information that could impact investor decisions, adhering to the rules of the stock exchanges where its securities are listed [2][3] - Information disclosed in one market must also be disclosed in the other market if the company’s securities are traded in both [2][3] Group 3: Types of Reports - The company is required to prepare and disclose periodic reports, including annual, semi-annual, and quarterly reports, which must contain significant financial data and operational information [12][13] - The annual report must be disclosed within four months after the fiscal year-end, while the semi-annual report must be disclosed within two months after the first half of the fiscal year [7][13] Group 4: Content of Reports - The annual report must include basic company information, major financial data, stock and bond issuance details, and significant events affecting the company [16] - The semi-annual report should cover similar content but can be unaudited unless specific conditions apply [9][12] Group 5: Temporary Reports - The company must disclose any major events that could significantly affect the trading price of its securities immediately upon occurrence [29] - Major events include significant changes in business operations, major investments, and legal issues [29][30] Group 6: Management Responsibilities - The board of directors is responsible for ensuring timely disclosure of periodic reports and must approve the content before it is released [15][20] - The board secretary plays a crucial role in managing the information disclosure process and ensuring compliance with regulations [51][52] Group 7: Internal Controls - The company must have internal procedures for reporting and disclosing significant information, ensuring that all relevant parties are informed promptly [26][27] - The board secretary and company secretary are responsible for overseeing the compliance of information disclosure and managing the related documentation [30][31]

Core Points - The document outlines the rules for the Compensation and Assessment Committee of Wuxi AppTec Co., Ltd, aiming to enhance the management of compensation and assessment for directors and senior management [2][3] - The committee is established under the board of directors and is responsible for formulating assessment standards, reviewing compensation policies, and researching equity incentive plans [2][5] Group 1: General Provisions - The committee is created to improve corporate governance and is based on various legal and regulatory frameworks [2] - The committee consists of three directors, with a majority being independent directors [3] Group 2: Responsibilities and Authority - The committee's main responsibilities include developing compensation plans based on the roles and responsibilities of directors and senior management, and ensuring transparency in the compensation process [5][6] - The committee is tasked with reviewing and approving compensation for non-independent directors and senior management, ensuring fairness and alignment with contractual terms [6][12] Group 3: Decision-Making Procedures - The committee is supported by a working group responsible for preparing proposals and providing necessary operational data [8][15] - Meetings require a two-thirds attendance of committee members, and decisions must be approved by a majority [9][10] Group 4: Meeting Regulations - Meetings must be documented, including attendance and voting results, and records should be maintained for at least ten years [10][11][28] - The committee has the authority to invite other directors and senior management to meetings when necessary [10][11] Group 5: Final Provisions - The rules take effect upon approval by the board and replace any previous regulations [29][30] - Any unresolved matters will be governed by relevant laws and regulations [30][31]